Jade Biosciences (JBIO) entered into a securities purchase agreement with BB Biotech (BBAGF) for a private placement financing that is expected to ...

The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...

Jade Road Investments ( ($GB:JADE) ) just unveiled an update. Jade Road Investments has issued a conversion notice to Woollard & Hall Ltd for the ...

The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...

Jade Currency, incorporated by Crypto Jade LLC in 2017, is an online marketplace that specifically targets the precious gem and cryptocurrency industries. Its native cryptocurrency token, JADE, is ...

Jade Biosciences, Inc. (Nasdaq: JBIO), a biotechnology company focused on autoimmune disease therapies, has announced the successful completion of its reverse merger and its debut on Nasdaq, along ...